PMC:7199903 / 11194-11456 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T44","span":{"begin":64,"end":72},"obj":"Disease"}],"attributes":[{"id":"A44","pred":"mondo_id","subj":"T44","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"oximate regions. Shielding of the receptor binding sites on the SARS-CoV-2 spike by proximal glycosylation sites (N165, N234, N343) can be observed, especially when the receptor binding domain is in the “down” conformation. The shielding of receptor binding site"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T56","span":{"begin":51,"end":56},"obj":"http://purl.obolibrary.org/obo/BFO_0000029"},{"id":"T57","span":{"begin":107,"end":112},"obj":"http://purl.obolibrary.org/obo/BFO_0000029"}],"text":"oximate regions. Shielding of the receptor binding sites on the SARS-CoV-2 spike by proximal glycosylation sites (N165, N234, N343) can be observed, especially when the receptor binding domain is in the “down” conformation. The shielding of receptor binding site"}

{"project":"LitCovid-sample-Enju","denotations":[{"id":"T23600","span":{"begin":8,"end":15},"obj":"NNS"},{"id":"T58449","span":{"begin":17,"end":26},"obj":"NN"},{"id":"T28529","span":{"begin":27,"end":29},"obj":"IN"},{"id":"T5747","span":{"begin":30,"end":33},"obj":"DT"},{"id":"T98568","span":{"begin":34,"end":42},"obj":"NN"},{"id":"T89375","span":{"begin":43,"end":50},"obj":"NN"},{"id":"T54690","span":{"begin":51,"end":56},"obj":"NNS"},{"id":"T85870","span":{"begin":57,"end":59},"obj":"IN"},{"id":"T26176","span":{"begin":60,"end":63},"obj":"DT"},{"id":"T37663","span":{"begin":64,"end":74},"obj":"NN"},{"id":"T63166","span":{"begin":75,"end":80},"obj":"NN"},{"id":"T63470","span":{"begin":81,"end":83},"obj":"IN"},{"id":"T24684","span":{"begin":84,"end":92},"obj":"JJ"},{"id":"T78149","span":{"begin":93,"end":106},"obj":"NN"},{"id":"T54872","span":{"begin":107,"end":112},"obj":"NNS"},{"id":"T62513","span":{"begin":113,"end":114},"obj":"-LRB-"},{"id":"T4900","span":{"begin":114,"end":118},"obj":"NN"},{"id":"T14840","span":{"begin":118,"end":119},"obj":"-COMMA-"},{"id":"T39942","span":{"begin":120,"end":124},"obj":"NN"},{"id":"T51156","span":{"begin":124,"end":125},"obj":"-COMMA-"},{"id":"T48381","span":{"begin":126,"end":130},"obj":"NN"},{"id":"T51553","span":{"begin":130,"end":131},"obj":"-RRB-"},{"id":"T58350","span":{"begin":132,"end":135},"obj":"MD"},{"id":"T58513","span":{"begin":136,"end":138},"obj":"VB"},{"id":"T19457","span":{"begin":139,"end":147},"obj":"VBN"},{"id":"T15145","span":{"begin":147,"end":148},"obj":"-COMMA-"},{"id":"T59932","span":{"begin":149,"end":159},"obj":"RB"},{"id":"T12181","span":{"begin":160,"end":164},"obj":"WRB"},{"id":"T47142","span":{"begin":165,"end":168},"obj":"DT"},{"id":"T6856","span":{"begin":169,"end":177},"obj":"NN"},{"id":"T18107","span":{"begin":178,"end":185},"obj":"NN"},{"id":"T3324","span":{"begin":186,"end":192},"obj":"NN"},{"id":"T48261","span":{"begin":193,"end":195},"obj":"VBZ"},{"id":"T13056","span":{"begin":196,"end":198},"obj":"IN"},{"id":"T67892","span":{"begin":199,"end":202},"obj":"DT"},{"id":"T64170","span":{"begin":203,"end":209},"obj":"JJ"},{"id":"T94966","span":{"begin":210,"end":222},"obj":"NN"},{"id":"T92249","span":{"begin":224,"end":227},"obj":"DT"},{"id":"T59586","span":{"begin":228,"end":237},"obj":"NN"},{"id":"T5292","span":{"begin":238,"end":240},"obj":"IN"},{"id":"T70689","span":{"begin":241,"end":249},"obj":"NN"},{"id":"T8257","span":{"begin":250,"end":257},"obj":"NN"}],"relations":[{"id":"R55910","pred":"arg2Of","subj":"T63166","obj":"T85870"},{"id":"R12247","pred":"arg1Of","subj":"T63166","obj":"T26176"},{"id":"R5833","pred":"arg1Of","subj":"T63166","obj":"T37663"},{"id":"R75194","pred":"arg1Of","subj":"T58449","obj":"T63470"},{"id":"R7830","pred":"arg2Of","subj":"T54872","obj":"T63470"},{"id":"R78332","pred":"arg1Of","subj":"T54872","obj":"T24684"},{"id":"R28714","pred":"arg1Of","subj":"T54872","obj":"T78149"},{"id":"R63825","pred":"arg1Of","subj":"T54872","obj":"T62513"},{"id":"R23552","pred":"arg2Of","subj":"T4900","obj":"T62513"},{"id":"R76217","pred":"arg1Of","subj":"T58449","obj":"T28529"},{"id":"R68250","pred":"arg2Of","subj":"T54690","obj":"T28529"},{"id":"R65618","pred":"arg1Of","subj":"T54690","obj":"T5747"},{"id":"R95409","pred":"arg1Of","subj":"T54690","obj":"T98568"},{"id":"R61306","pred":"arg1Of","subj":"T54690","obj":"T89375"},{"id":"R2818","pred":"arg1Of","subj":"T58449","obj":"T85870"},{"id":"R91387","pred":"arg3Of","subj":"T51553","obj":"T62513"},{"id":"R43856","pred":"arg1Of","subj":"T4900","obj":"T14840"},{"id":"R84383","pred":"arg2Of","subj":"T39942","obj":"T14840"},{"id":"R66425","pred":"arg1Of","subj":"T4900","obj":"T51156"},{"id":"R43336","pred":"arg2Of","subj":"T48381","obj":"T51156"},{"id":"R88573","pred":"arg1Of","subj":"T58449","obj":"T58350"},{"id":"R51019","pred":"arg2Of","subj":"T19457","obj":"T58350"},{"id":"R48795","pred":"arg1Of","subj":"T58449","obj":"T58513"},{"id":"R86137","pred":"arg2Of","subj":"T19457","obj":"T58513"},{"id":"R24299","pred":"arg2Of","subj":"T58449","obj":"T19457"},{"id":"R42170","pred":"arg1Of","subj":"T19457","obj":"T15145"},{"id":"R74106","pred":"arg1Of","subj":"T19457","obj":"T59932"},{"id":"R88232","pred":"arg2Of","subj":"T48261","obj":"T59932"},{"id":"R69825","pred":"arg1Of","subj":"T59932","obj":"T12181"},{"id":"R78666","pred":"arg1Of","subj":"T3324","obj":"T47142"},{"id":"R34699","pred":"arg1Of","subj":"T3324","obj":"T6856"},{"id":"R11304","pred":"arg1Of","subj":"T3324","obj":"T18107"},{"id":"R64017","pred":"arg1Of","subj":"T3324","obj":"T48261"},{"id":"R82933","pred":"arg2Of","subj":"T13056","obj":"T48261"},{"id":"R15661","pred":"arg1Of","subj":"T3324","obj":"T13056"},{"id":"R76241","pred":"arg2Of","subj":"T94966","obj":"T13056"},{"id":"R92771","pred":"arg1Of","subj":"T94966","obj":"T67892"},{"id":"R81579","pred":"arg1Of","subj":"T94966","obj":"T64170"},{"id":"R10980","pred":"arg1Of","subj":"T59586","obj":"T92249"},{"id":"R20672","pred":"arg1Of","subj":"T59586","obj":"T5292"}],"text":"oximate regions. Shielding of the receptor binding sites on the SARS-CoV-2 spike by proximal glycosylation sites (N165, N234, N343) can be observed, especially when the receptor binding domain is in the “down” conformation. The shielding of receptor binding site"}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T43","span":{"begin":64,"end":74},"obj":"Species"}],"attributes":[{"id":"A43","pred":"ncbi_taxonomy_id","subj":"T43","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"oximate regions. Shielding of the receptor binding sites on the SARS-CoV-2 spike by proximal glycosylation sites (N165, N234, N343) can be observed, especially when the receptor binding domain is in the “down” conformation. The shielding of receptor binding site"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T77","span":{"begin":17,"end":223},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"oximate regions. Shielding of the receptor binding sites on the SARS-CoV-2 spike by proximal glycosylation sites (N165, N234, N343) can be observed, especially when the receptor binding domain is in the “down” conformation. The shielding of receptor binding site"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T38","span":{"begin":64,"end":74},"obj":"Disease"}],"attributes":[{"id":"A38","pred":"mondo_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"oximate regions. Shielding of the receptor binding sites on the SARS-CoV-2 spike by proximal glycosylation sites (N165, N234, N343) can be observed, especially when the receptor binding domain is in the “down” conformation. The shielding of receptor binding site"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"376","span":{"begin":75,"end":80},"obj":"Gene"},{"id":"377","span":{"begin":64,"end":74},"obj":"Species"}],"attributes":[{"id":"A376","pred":"pubann:denotes","subj":"376","obj":"Gene:43740568"},{"id":"A377","pred":"pubann:denotes","subj":"377","obj":"Tax:2697049"}],"text":"oximate regions. Shielding of the receptor binding sites on the SARS-CoV-2 spike by proximal glycosylation sites (N165, N234, N343) can be observed, especially when the receptor binding domain is in the “down” conformation. The shielding of receptor binding site"}

{"project":"LitCovid-sample-PD-MAT","denotations":[{"id":"T3","span":{"begin":84,"end":92},"obj":"http://purl.obolibrary.org/obo/MAT_0000491"}],"text":"oximate regions. Shielding of the receptor binding sites on the SARS-CoV-2 spike by proximal glycosylation sites (N165, N234, N343) can be observed, especially when the receptor binding domain is in the “down” conformation. The shielding of receptor binding site"}

{"project":"LitCovid-sample-PD-GO-BP-0","denotations":[{"id":"T34","span":{"begin":93,"end":106},"obj":"http://purl.obolibrary.org/obo/GO_0070085"}],"text":"oximate regions. Shielding of the receptor binding sites on the SARS-CoV-2 spike by proximal glycosylation sites (N165, N234, N343) can be observed, especially when the receptor binding domain is in the “down” conformation. The shielding of receptor binding site"}

{"project":"LitCovid-sample-GO-BP","denotations":[{"id":"T32","span":{"begin":93,"end":106},"obj":"http://purl.obolibrary.org/obo/GO_0070085"}],"text":"oximate regions. Shielding of the receptor binding sites on the SARS-CoV-2 spike by proximal glycosylation sites (N165, N234, N343) can be observed, especially when the receptor binding domain is in the “down” conformation. The shielding of receptor binding site"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T37","span":{"begin":93,"end":106},"obj":"http://purl.obolibrary.org/obo/GO_0070085"}],"text":"oximate regions. Shielding of the receptor binding sites on the SARS-CoV-2 spike by proximal glycosylation sites (N165, N234, N343) can be observed, especially when the receptor binding domain is in the “down” conformation. The shielding of receptor binding site"}

{"project":"LitCovid-sentences","denotations":[{"id":"T77","span":{"begin":17,"end":223},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"oximate regions. Shielding of the receptor binding sites on the SARS-CoV-2 spike by proximal glycosylation sites (N165, N234, N343) can be observed, especially when the receptor binding domain is in the “down” conformation. The shielding of receptor binding site"}

{"project":"LitCovid-PubTator","denotations":[{"id":"376","span":{"begin":75,"end":80},"obj":"Gene"},{"id":"377","span":{"begin":64,"end":74},"obj":"Species"}],"attributes":[{"id":"A376","pred":"tao:has_database_id","subj":"376","obj":"Gene:43740568"},{"id":"A377","pred":"tao:has_database_id","subj":"377","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"oximate regions. Shielding of the receptor binding sites on the SARS-CoV-2 spike by proximal glycosylation sites (N165, N234, N343) can be observed, especially when the receptor binding domain is in the “down” conformation. The shielding of receptor binding site"}